Jayesh A. Kulkarni

9.6k total citations · 9 hit papers
47 papers, 7.2k citations indexed

About

Jayesh A. Kulkarni is a scholar working on Molecular Biology, Biomaterials and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Jayesh A. Kulkarni has authored 47 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 10 papers in Biomaterials and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Jayesh A. Kulkarni's work include RNA Interference and Gene Delivery (33 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Lipid Membrane Structure and Behavior (15 papers). Jayesh A. Kulkarni is often cited by papers focused on RNA Interference and Gene Delivery (33 papers), Advanced biosensing and bioanalysis techniques (19 papers) and Lipid Membrane Structure and Behavior (15 papers). Jayesh A. Kulkarni collaborates with scholars based in Canada, Netherlands and United States. Jayesh A. Kulkarni's co-authors include Pieter R. Cullis, Dominik Witzigmann, Roy van der Meel, Sam Chen, Yuen Yi C. Tam, Rein Verbeke, Wim Jiskoot, Linde Schoenmaker, Gideon Kersten and Daan J.A. Crommelin and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Accounts of Chemical Research.

In The Last Decade

Jayesh A. Kulkarni

45 papers receiving 7.2k citations

Hit Papers

The Onpattro story and the clinical translation of nanome... 2018 2026 2020 2023 2019 2021 2021 2022 2018 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
    2019 1.2k citations Akin Akinc, Martin A. Maier et al. Nature Nanotechnology profile →
  2. mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
    2021 1.0k citations Dominik Witzigmann, Jayesh A. Kulkarni et al. International Journal of Pharmaceutics profile →
  3. The current landscape of nucleic acid therapeutics
    2021 934 citations Jayesh A. Kulkarni, Dominik Witzigmann et al. Nature Nanotechnology profile →
  4. The role of lipid components in lipid nanoparticles for vaccines and gene therapy
    2022 718 citations Jayesh A. Kulkarni, Dominik Witzigmann et al. profile →
  5. On the Formation and Morphology of Lipid Nanoparticles Containing Ionizable Cationic Lipids and siRNA
    2018 457 citations Jayesh A. Kulkarni, Sam Chen et al. ACS Nano profile →
  6. Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility
    2018 411 citations Jayesh A. Kulkarni, Pieter R. Cullis et al. profile →
  7. Lipid Nanoparticle Technology for Clinical Translation of siRNA Therapeutics
    2019 376 citations Jayesh A. Kulkarni, Dominik Witzigmann et al. profile →
  8. Lipid nanoparticle technology for therapeutic gene regulation in the liver
    2020 273 citations Dominik Witzigmann, Jayesh A. Kulkarni et al. profile →
  9. Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency
    2023 129 citations Miffy H. Y. Cheng, Jerry Leung et al. Advanced Materials profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jayesh A. Kulkarni Canada 28 5.8k 1.1k 1.0k 995 797 47 7.2k
Yizhou Dong United States 45 6.4k 1.1× 1.3k 1.2× 1.1k 1.1× 1.6k 1.6× 920 1.2× 110 9.3k
Qiang Cheng China 37 5.4k 0.9× 1.2k 1.1× 1.2k 1.2× 850 0.9× 469 0.6× 86 6.9k
Gaurav Sahay United States 37 5.7k 1.0× 1.8k 1.6× 2.1k 2.0× 810 0.8× 526 0.7× 69 8.4k
James E. Dahlman United States 40 5.0k 0.9× 1.5k 1.4× 1.4k 1.3× 795 0.8× 404 0.5× 76 7.3k
Dominik Witzigmann Canada 31 6.2k 1.1× 2.0k 1.9× 2.3k 2.3× 1.0k 1.0× 704 0.9× 64 9.1k
Roy van der Meel Netherlands 31 5.6k 1.0× 1.9k 1.7× 1.8k 1.8× 1.1k 1.1× 515 0.6× 51 7.9k
Barbara L. Mui United States 27 5.2k 0.9× 540 0.5× 671 0.7× 1.3k 1.3× 1.2k 1.5× 36 6.5k
Martin A. Maier United States 38 6.9k 1.2× 666 0.6× 746 0.7× 753 0.8× 440 0.6× 88 8.0k
Enrico Mastrobattista Netherlands 45 4.4k 0.8× 1.4k 1.3× 1.7k 1.7× 877 0.9× 349 0.4× 137 6.9k
Thomas D. Madden Canada 34 5.6k 1.0× 831 0.8× 1.4k 1.4× 1.1k 1.1× 1.1k 1.3× 63 7.5k

Countries citing papers authored by Jayesh A. Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Jayesh A. Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jayesh A. Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jayesh A. Kulkarni more than expected).

Fields of papers citing papers by Jayesh A. Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jayesh A. Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jayesh A. Kulkarni. The network helps show where Jayesh A. Kulkarni may publish in the future.

Co-authorship network of co-authors of Jayesh A. Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Jayesh A. Kulkarni. A scholar is included among the top collaborators of Jayesh A. Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jayesh A. Kulkarni. Jayesh A. Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saadati, Fariba, et al.. (2025). Design of cationic ionizable lipids for the delivery of therapeutic nucleic acids. Molecular Therapy — Methods & Clinical Development. 33(4). 101585–101585. 1 indexed citations
2.
Brimacombe, Cedric A., et al.. (2025). Rational design of lipid nanoparticles for enabling gene therapies. Molecular Therapy — Methods & Clinical Development. 33(3). 101518–101518. 2 indexed citations
3.
Schmidt, Konrad, Jerry Leung, January Weiner, et al.. (2025). Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles. Journal of Controlled Release. 385. 114053–114053.
4.
Leung, Ada W.Y., Roger Gilabert‐Oriol, Jayesh A. Kulkarni, et al.. (2025). Liposomal delivery of a disulfiram metabolite drives copper-mediated tumor immunity. International Journal of Pharmaceutics. 683. 126010–126010.
5.
Zhang, Yao, Romain Berti, Benjamin Wang, et al.. (2024). Quantitative Visualization of Lipid Nanoparticle Fusion as a Function of Formulation and Process Parameters. ACS Nano. 18(28). 18191–18201. 15 indexed citations
6.
Basha, Genc, et al.. (2023). A luciferase reporter mouse model to optimize in vivo gene editing validated by lipid nanoparticle delivery of adenine base editors. Molecular Therapy. 31(4). 1159–1166. 12 indexed citations
7.
Cheng, Miffy H. Y., Jerry Leung, Yao Zhang, et al.. (2023). Induction of Bleb Structures in Lipid Nanoparticle Formulations of mRNA Leads to Improved Transfection Potency. Advanced Materials. 35(31). e2303370–e2303370. 129 indexed citations breakdown →
8.
Tam, Anthony Raymond, Jayesh A. Kulkarni, Delbert R. Dorscheid, et al.. (2022). Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways. European Journal of Pharmaceutical Sciences. 176. 106234–106234. 27 indexed citations
9.
Zhigaltsev, Igor V., Yuen Yi C. Tam, Jayesh A. Kulkarni, & Pieter R. Cullis. (2022). Synthesis and Characterization of Hybrid Lipid Nanoparticles Containing Gold Nanoparticles and a Weak Base Drug. Langmuir. 38(25). 7858–7866. 12 indexed citations
10.
Schuetz, Mathias, Faride Unda, Marcel B. Bally, et al.. (2022). Monolignol export by diffusion down a polymerization-induced concentration gradient. The Plant Cell. 34(5). 2080–2095. 42 indexed citations
11.
Kulkarni, Jayesh A., Dominik Witzigmann, Sarah B. Thomson, et al.. (2021). Author Correction: The current landscape of nucleic acid therapeutics. Nature Nanotechnology. 16(7). 841–841. 16 indexed citations
12.
Kulkarni, Jayesh A., Dominik Witzigmann, Sarah B. Thomson, et al.. (2021). The current landscape of nucleic acid therapeutics. Nature Nanotechnology. 16(6). 630–643. 934 indexed citations breakdown →
13.
Meel, Roy van der, Sam Chen, Josh Zaifman, et al.. (2021). Modular Lipid Nanoparticle Platform Technology for siRNA and Lipophilic Prodrug Delivery. Small. 17(37). e2103025–e2103025. 42 indexed citations
14.
Kulkarni, Jayesh A., Sarah B. Thomson, Josh Zaifman, et al.. (2020). Spontaneous, solvent-free entrapment of siRNA within lipid nanoparticles. Nanoscale. 12(47). 23959–23966. 49 indexed citations
15.
Meixner, Scott C., Jerry Leung, Jayesh A. Kulkarni, et al.. (2020). Sustained depletion of FXIII-A by inducing acquired FXIII-B deficiency. Blood. 136(25). 2946–2954. 25 indexed citations
16.
Akinc, Akin, Martin A. Maier, Muthiah Manoharan, et al.. (2019). The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs. Nature Nanotechnology. 14(12). 1084–1087. 1160 indexed citations breakdown →
17.
Anantha, Malathi, Ada W.Y. Leung, Jayesh A. Kulkarni, et al.. (2019). Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use. Drug Delivery and Translational Research. 10(1). 202–215. 29 indexed citations
18.
Uhl, Philipp, Max Sauter, Anja Tursch, et al.. (2019). Coating of PLA-nanoparticles with cyclic, arginine-rich cell penetrating peptides enables oral delivery of liraglutide. Nanomedicine Nanotechnology Biology and Medicine. 24. 102132–102132. 52 indexed citations
19.
20.
Kulkarni, Jayesh A., et al.. (2016). Design of lipid nanoparticles for in vitro and in vivo delivery of plasmid DNA. Nanomedicine Nanotechnology Biology and Medicine. 13(4). 1377–1387. 176 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yizhou Dong Breakdown of academic impact, for papers by Qiang Cheng Breakdown of academic impact, for papers by Gaurav Sahay Breakdown of academic impact, for papers by James E. Dahlman Breakdown of academic impact, for papers by Dominik Witzigmann Breakdown of academic impact, for papers by Roy van der Meel Breakdown of academic impact, for papers by Barbara L. Mui Breakdown of academic impact, for papers by Martin A. Maier Breakdown of academic impact, for papers by Enrico Mastrobattista Breakdown of academic impact, for papers by Thomas D. Madden
Rankless by CCL
2026